Development of and Access to Products for Neglected Diseases

INTRODUCTION: Prior research on neglected disease drug development suggested inadequate funding was responsible for relatively few new approvals. In response, significantly more resources have been allocated towards development of drugs targeting neglected diseases. Our objective was to reassess dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Joshua, Dibner, Maria Staroselsky, Wilson, Andrew
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868904/
https://www.ncbi.nlm.nih.gov/pubmed/20485552
http://dx.doi.org/10.1371/journal.pone.0010610

Ejemplares similares

Ejemplares similares